Recurring concern

Unreliable clinical safety-alert systems

Pin Get email alerts Request correction

First reported 12 Oct 2013•Latest report 1 Apr 2026

Definition

What this concern includes

Includes failures of clinical records, prescribing systems or related clinical information processes to create, retain, update, display or otherwise reliably surface safety alerts concerning patients, medicines or treatment.

Not included

  • Excludes failures to act on a clearly received alert where the alerting system itself operated as intended.
  • Excludes non-clinical alert systems such as police, custody, safeguarding or transport systems unless the report directly concerns a clinical safety-alert system.
  • Excludes generic record-keeping or communication deficiencies that are not specifically tied to the reliability of a clinical safety alert.
Reports
53

Distinct published reports

Individual concerns
56

A report can raise multiple concerns

Date range
2013–2026

First to latest report issue date

Stated actions
66

Described in published responses

Reports over time

Reports over time

Reports about this concern issued each year.

* 2026 is projected from reports observed to 7 Sep 2026.

Most frequent recipients

Most frequent recipients

Reports about this concern sent to each recipient.

NHS England12
Department of Health and Social Care11
Egton Medical Information Systems Limited3
Medicines and Healthcare products Regulatory Agency3
Barts Health NHS Trust2
Care Quality Commission2
Great Western Hospitals NHS Foundation Trust2
Medway NHS Foundation Trust2
NHS Wales2
Proprietary Association of Great Britain2
Royal College of General Practitioners2
Royal Cornwall Hospitals NHS Trust2
Welsh Government2
Adelaide Medical Centre, London1
Alliance Pharmaceuticals Limited1

Concerns and responses across reports

Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.

  1. Gateshead and South Tyneside

    AI-generated summary

    ARCHIE RAY GRIEVES · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Archie Ray Grieves was born on 24 May 2017 following a complicated delivery involving shoulder dystocia. He initially showed no signs of life, later showed signs of life, and died a short time after being taken to the special care baby unit. The report identified an avoidable neonatal death, with an eight-minute delay in delivering his body after his head and missed opportunities during antenatal care and delivery to identify risks and plan a safe birth.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to red-flag significant maternal and fetal growth findings in records

    Wider context from the report

    “23.The missed opportunities in this matter would have been avoided if significant findings had been “red flagged” within mother’s records. A significant finding being something which is potentially likely to impact on the management and care of the patient at some stage during their journey and more particularly one identified as factors in the policies and practices of the Trust determined to ensure the safe care of the patient and in this case mother and baby. 24.Such red flags in this matter would and should have highlighted : a) A heightened BMI b) A Fundal height above and outwith the gestational norm 25.As an added aid to safe management and care such “red flags” should cross reference specific Policies/protocols where such issues contra- indicate certain strategies (birthing pools and increased BMI large baby) or alert for protective planning and preparation 26.The fact that the Growth Chart in this matter :- a) demonstrated the baby to be large for his gestational age and b) there was an apparent lack of understanding appreciation /conflict as to the significance of The Chart as well as c) an inability to interpret The Chart by nursing and medical staff and d) more importantly a lack of awareness that such a measure should in accordance with established Trust policy have lead to a Obstetric referral and consultation, together leads to :- ”

    Source location

    ARCHIE RAY GRIEVES · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report
  2. Oxfordshire

    AI-generated summary

    Marian Grant · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Marian Grant, aged 74, tripped and fell on 14 April 2018 and died from a pulmonary embolism during surgery for a fractured neck of femur on 16 April 2018. The principal concerns were the omission of VTE prophylaxis, particularly for patients placed on non-trauma wards, and the failure of EPR alerts and other checks to ensure that prophylaxis was prescribed and acted upon.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure of EPR VTE alerts to appear when records remain open

    Wider context from the report

    “2. The second concern relates to ignoring the VTE prophylaxis alerts on EPR. I note from the RCA Report that the warning was visible on exiting the record by all staff. ████████ explained however that often the warning would not be seen because sometimes a doctor does not actually exit the record but keeps it open (albeit secure). It is surprising that from the time of transfer to the neuro-science ward from ED until the time when the patient was seen by the Consultant Anaesthetist ████████ on the morning of surgery on 16 April that the EPR was accessed 27 times by staff members and yet none of the staff interviewed recalled seeing the alert. A system designed with fail-safes in the form of alerts is obviously not effective if the alerts are not seen or routinely ignored. Recommendation 8 on the Action Plan refers to this issue and I see that an email has been sent out to the EPR Lead and that a new version of EPR will prevent staff being able to exit the EPR record until VTE alerts have been dealt with. As mentioned, it seems though that doctors do not always exit the record and, as I understand it, the alert will not pop up unless the record is being exited. It would be appreciated if you could provide some clarification on this and also address the wider issue of alerts not being acted upon. ”

    Source location

    Marian Grant · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report
  3. Inner North London

    AI-generated summary

    Flora Marion BABER · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Flora Marion Baber was admitted to the Royal Free Hospital from Compton Lodge Care Home on 25 January 2018 with increased confusion, slurred speech and difficulty breathing, and died there about a month later. Concerns included inadequate access to fluids, inappropriate food and eating assistance, delays in speech and language referral and treatment of oral thrush, an apparently sleeping staff member, inappropriate responses to toileting requests, and failure to record her opioid sensitivity across healthcare settings.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to record opioid sensitivity as an alert across care records

    Wider context from the report

    “5. Dr Baber had a sensitivity to opioids, such that her family noted a direct correlation between episodes of sickness and vomiting, and the administration of opioid medication. This had been recognised and recorded during earlier admissions to the Royal Free, and family had discussed with staff at the care home. However, it was not recorded as an alert on her hospital notes, or on her general practitioner notes, or on the care home notes. At the very end of Dr Baber’s life, the benefit of pain relief was thought to outweigh the side effects of opiates, but before then her sensitivity was simply not recognised. This caused her discomfort and distress, and in another case could have fatal consequences. ”

    Source location

    Flora Marion BABER · Prevention of Future Deaths report
    Page 3 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Introduce a transfer checklist ensuring required medical history and care information accompanies residents between homes and hospitals.

    Verbatim wording from the response

    “i) To ensure that the correct documentation is sent with a resident on transfer, a check list has been introduced for C&C Care Homes since the death of Dr Baber. This is to ensure the person in charge has considered and included all the required documentation and information about the resident's medical history and needs.”

    Source location

    2018-0299-Response-by-CC-Housing-Trust
    Page 3 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Introduce an electronic care-plan system and update training for staff who review and update care plans.

    Verbatim wording from the response

    “v) It is C&C's intention to introduce an electronic care plan system, which will prompt staff to complete and update all relevant information in order to ensure that all questions are considered. C&C are in talks with potential suppliers for this new system, and we intend to introduce this, together with updating training for all staff tasked with reviewing and updating care plans, in the first quarter of next year.”

    Source location

    2018-0299-Response-by-CC-Housing-Trust
    Page 4 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Roll out enhanced refresher training on care-plan documentation, medication administration, and recording residents’ conditions and needs across C&C homes.

    Verbatim wording from the response

    “i) Since the incident at Compton Lodge, C&C have reviewed and increased the training given to staff across all of its Homes, around care plan documentation and medication administration, to ensure our residents' safety. Further training focuses upon good practice around recording and evidencing information about the residents' conditions and needs, which is discussed and demonstrated in full. This has been developed as part of staff refresher training, which is currently being rolled out throughout our Care Homes, by our Quality and Compliance Manager. This should be completed by the end of this year.”

    Source location

    2018-0299-Response-by-CC-Housing-Trust
    Page 5 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Implement rigorous checks for maintaining current care-plan and medication records, delete obsolete electronic care-plan forms, and roll these controls out across C&C homes.

    Verbatim wording from the response

    “ii) Since the new Home Manager at Compton Lodge was appointed in June 2018, more rigorous checks have been put in place to ensure that the procedures for care plans and medication records to be updated and maintained are followed consistently. The storage of old care plan forms on local computers have been deleted to ensure that new and relevant information only is added to the correct, up to date version of care plan documentation for each resident. These improvements and checks have also been rolled out across our other care Homes. Moving forward, this discipline will be closely monitored by the Quality and Compliance Manager and continued improvements made across all of C&C's Homes.”

    Source location

    2018-0299-Response-by-CC-Housing-Trust
    Page 5 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Remind staff to record and check allergies and sensitivities on every admission and discharge, including manual updates to TTA forms and drug charts.

    Verbatim wording from the response

    “Learning from this incident has already been shared with Pharmacy staff as well as at junior doctor prescribing teaching sessions to remind them all that allergies and sensitivities must be recorded and checked on each admission and discharge. The action to mitigate recurrence is to ensure that all staff are reminded about the need to manually record allergy/sensitives on the Freenet TTA form and drug charts.”

    Source location

    2018-0299-Response-by-Royal-Free-London-Hospitsl-NHS-Trust
    Page 7 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Develop an electronic process with IT and Cerner to record allergy information at admission and transfer it to discharge documentation, including assessing backdating options.

    Verbatim wording from the response

    “As a short term solution pharmacy are exploring the option with IT/Cerner to assess the best possible way to record allergies and transfer them from the point of admission (recording of allergy status on Cerner) to the automated pull of this data to the Freenet TTA. We would like to continue the current option of manual amendment of the allergy status on the Freenet TTA (as this can change through the patient’s stay in the hospital). We hope that Doctors, nurses, and pharmacists will be allowed the option to amend the allergy status in Freenet and Power chart on Cerner. There are a number of separate sets of programming codes for different templates required to implement these changes so this will take some time to embed, but the IT department have begun working on this.”

    Source location

    2018-0299-Response-by-Royal-Free-London-Hospitsl-NHS-Trust
    Page 7 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Introduce EPR/EPMA functionality to populate discharge documentation with allergy status and prompt staff when allergy information is missing.

    Verbatim wording from the response

    “In the long term, once EPR/ EPMA (electronic prescribing system) is introduced in the trust this will automatically populate the TTA/discharge summary with the allergy status of the patient from the electronic prescription. It is expected that this will go live at Barnet and Chase Farm by the end of this year, and will be rolled out across the Royal Free site in 2019. There will be prompts on this system to alert staff when an allergy has not been recorded, and it will be more easily auditable than the current system.”

    Source location

    2018-0299-Response-by-Royal-Free-London-Hospitsl-NHS-Trust
    Page 7 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Discussed appropriate coding of clinically significant opioid sensitivities in GP notes.

    Verbatim wording from the response

    “• 18/09/2019: Meeting ████████, ████████ (Managing partner) and ████████ (Practice Manager); to discuss how the sensitivity to opioids could have been coded appropriately in the GP notes”

    Source location

    2018-0299-Response-by-Adelaide-Medical-Centre
    Page 1 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Shared learning on recording opioid sensitivities with Royal Free Hospital and Compton Lodge representatives.

    Verbatim wording from the response

    “• 18/09/2019: Meeting ████████████████████ (Royal Free Geriatrician), ████████ Compton Lodge Dept Care Home Manager; To share Adelaide’s learning and see how this may support recording at the Royal Free and Compton Lodge.”

    Source location

    2018-0299-Response-by-Adelaide-Medical-Centre
    Page 1 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Recorded the learning in an internal significant event and shared it with all practice clinicians, including the opioid-sensitivity alerting process.

    Verbatim wording from the response

    “• This reflection/learning has been captured in a significant event and shared with the other clinicians in the practice.”

    Source location

    2018-0299-Response-by-Adelaide-Medical-Centre
    Page 2 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Care staff cannot diagnose medication allergies or sensitivities and therefore cannot record family concerns in care plans without clinical confirmation.

    Verbatim wording from the response

    “Any changes in the condition of the resident, including allergies, would also be noted on their care plan by the Team Leader, being informed by the hospital discharge letter and / or advice from the GP. Our residential Care Homes are not staffed by clinicians who are qualified to make diagnoses of medication allergies or sensitivities. We rely wholly on the GP, treating doctors and hospitals to communicate any medical changes and medication updates relevant to our residents.”

    Source location

    2018-0299-Response-by-CC-Housing-Trust
    Page 1 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    GPs, treating doctors and hospitals must provide official clinical advice before medication allergies or changes can be recorded and communicated to pharmacists.

    Verbatim wording from the response

    “It is important to clarify that if a resident develops an allergy to medication during their stay with us, we would expect confirmation from their GP or hospital before making any amendment to their care plan. Any information about a resident's allergy to medication would be advised in hospital discharge notes, or by the doctors in the form of an official letter. When a resident returns from hospital, a discharge letter should always be sent and a copy provided to the resident's GP to ensure that their records and those of the pharmacist are updated. Any advice concerning medication prescribed or any changes to such medication or dosage should also be recorded on their MAR chart.”

    Source location

    2018-0299-Response-by-CC-Housing-Trust
    Page 1 · response
    Published 24 January 2019

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Systematic alerting of opioid sensitivities between hospital and GP practice cannot be implemented until the planned new IT system is available.

    Verbatim wording from the response

    “• RFH felt it was not possible to consider a more systematic alerting of sensitivities/allergies between RFH to GP practice until the new IT system (planned for ~12mths) is implemented. Therefore, no process change to be considered at this time.”

    Source location

    2018-0299-Response-by-Adelaide-Medical-Centre
    Page 3 · response
    Published 24 January 2019

    Open published response
  4. West Yorkshire (Western)

    AI-generated summary

    Brian Leonard Bicat · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Brian Leonard Bicat sustained severe burns at home on 22 September 2017 when his dressing gown caught fire while he was smoking a cigarette. He died later that day from his extensive cutaneous burns, with evidence indicating that paraffin-based emollient creams and ointments increased the speed and intensity of the fire. The principal concerns were that low-paraffin emollients may pose a fire hazard, that warnings were not displayed consistently on packaging or communicated by healthcare professionals, and that related prescribing alerts and incident data were inconsistent or incomplete.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Inconsistent fire-risk alerts and warnings across NHS prescribing systems

    Wider context from the report

    “The NHS prescribing systems (system One and Optimise) appear to be updated by individual CCG’s resulting inconsistent alerts and warnings. ”

    Source location

    Brian Leonard Bicat · Prevention of Future Deaths report
    Page 3 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Create a SystmOne alert identifying patients at risk when emollient treatment is entered in the clinical record.

    Verbatim wording from the response

    “5. An alert has been created on our clinical records system, SystmOne. This is an electronic icon indicating that a patient is at risk when emollient is entered into the clinical record.”

    Source location

    2018-0277-Response-by-Bradford-District-Care-NHS-Trust
    Page 1 · response
    Published 30 October 2018

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Other recipients of the report will address concerns about healthcare warnings, prescribing systems, incident data and fire-safety training.

    Verbatim wording from the response

    “Bayer's response to items 1-5 is provided below. We understand that other recipients of the Report will address items 6-12.”

    Source location

    2018-0277-Response-by-Alliance-Pharmaceuticals-and-Bayer
    Page 4 · response
    Published 30 October 2018

    Open published response
  5. London (East)

    AI-generated summary

    Caliel Arlington SMITH-KWAMI · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Caliel Arlington Smith-Kwami suffered a profound hypoglycaemic episode around 28 hours after birth and later died on 17 August 2016 from persistent neonatal hyperinsulinaemic hypoglycaemia. He was discharged before key test results were obtained, and concerns included failures to notify clinicians that results were delayed or available, unclear responsibility for chasing results, and a missed opportunity to involve community midwives.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of electronic record alerts to clinical staff when results are ready

    Wider context from the report

    “(3)The results of the amino acid profile, which raised the possibility of hyperinsulinism were sent through to the electronic record system on the 9 August 2016. It does not appear that any clinician was aware of this result prior to Caliel’s death. The Consultant in Charge of Caliel’s care stated there is no system in place with the electronic record system for highlighting to clinical staff that results are ready. He stated that when paper records were in place, clinicians would result the paper result, but this notification has now been lost. ”

    Source location

    Caliel Arlington SMITH-KWAMI · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report
  6. Cornwall and Isles of Scilly

    AI-generated summary

    Pauline May Pryor · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Pauline May Pryor, a resident of Trevornor Nursing Home receiving lithium treatment, was found unwell on 9 July 2015 and died in hospital on 13 July 2015. The report identified concerns that required quarterly blood tests were not carried out because of unclear communication between the nursing home and GP surgery, and that psychiatric advice to reduce and stop lithium was not seen or followed up.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure of clinical alert processes to reflect applicable lithium monitoring guidelines

    Wider context from the report

    “• Mrs Pryor suffered from bipolar affective disorder and was on Lithium treatment which had been successful for many years in controlling her mood. Patients on Lithium are required to have quarterly blood tests to check kidney function and lithium levels. This was not carried out for a number of reasons do to with unclear communication between the Nursing Home and GP surgery. The practice did have in place a computer system to highlight test/reviews for certain groups of patients based on “Quality Outcome Framework Targets” (QOF) guidelines and were unaware these did not necessarily mirror the NICE Guidelines or Local Prescribing /Care Guidelines such as in the case of Lithium Toxicity • A blood test on 29th April 2015 showed Mrs Pryor’s kidney function dropped (eGFR 25) despite a lithium test being requested by Nursing Home and GP it did not occurred. As a result of the kidney function test result the GP wrote to Mrs Pryor’s Consultant Psychiatrist for advice on medication. The Psychiatrist replied by e-mail on the 15.6.15 and advised the GP to reduce and stop the Lithium medication. The E-mail was sent to the GP Practice e-mail but was not seen by the GP for reasons unknown nor was the reply chased up ”

    Source location

    Pauline May Pryor · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Highlight lithium monitoring requirements to GPs and practices and remind them that current BNF and local CCG prescribing guidance is available.

    Verbatim wording from the response

    “2. Lithium monitoring. Thank you for pointing out that the QOF framework which is designed to reward GPs for quality, is not the mirror of lithium monitoring guidelines. We will ensure that this is highlighted to GPs and practices and a reminder that up to date guidance is available from the latest BNF, and also local CCG prescribing guidelines.”

    Source location

    2018-0008-Response-by-NHS-England
    Page 1 · response
    Published 7 March 2018

    Open published response
  7. Manchester West

    AI-generated summary

    Terence Ryan · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Terence Ryan died on 14 November 2016 after a road traffic collision caused a left leg fracture and he later self-discharged from hospital without anticoagulation medication. The report identified concerns about a consultant-prescribed anticoagulant not being added to his repeat prescriptions and the absence of a hospital protocol for patients, particularly vulnerable patients, who self-discharge without necessary medication.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of alerts for new medications subject to repeat prescription

    Wider context from the report

    “i. On the 15th July 2016 a Consultant prescribed Edoxaban 60mg per day for long term anticoagulation treatment to be collected by the deceased on a weekly basis by repeat prescription issued by the General Practitioner and the Consultant sent a letter to the General Practitioner to confirm that plan of treatment. The repeat prescription for Edoxaban was not put on the deceased’s repeat prescriptions by the General Practitioner and the deceased did not receive Edoxaban for administration after the 22nd July 2016 and he would not have had a supply of Edoxaban following his self-discharge from the Hospital on the 10th November 2016. The General Practitioner gave evidence that the Surgery had undertaken a “Significant Event Analysis” as to how the Edoxaban prescription had been missed and the investigation resulted in the following recommendations within the Surgery to prevent a recurrence:- a. GP to review “active problems” on the computer system when any patient comes in, in order to ensure patient is on the appropriate treatment. b. In respect of discharge letters directing new medication – the letter will be sent on a task to a prescription clerk, who will add the new medication and issue a month’s supply. If necessary (depending on the type of medication involved) the task will include sending a request to the patient to see the GP for review in a month’s time. However, the General Practitioner confirmed that the above recommendations had not been included in any formal documented protocol and I was not satisfied that there was to be a note on a patient’s record to alert a Doctor to a new medication subject to repeat prescription, bearing in mind that the deceased had seen a General Practitioner on the 13th September 2016, the 30th September 2016 and the 14th October 2016 without the omission being checked. ”

    Source location

    Terence Ryan · Prevention of Future Deaths report
    Page 3 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Study and discuss the repeat prescribing and scanning protocols at a practice meeting.

    Verbatim wording from the response

    “I enclose copies of our Repeat Prescribing Protocol; this includes the ‘Protection on Prescribing’ including hospital letters.”

    Source location

    2017-0225-Response-by-Grasmere-Surgery
    Page 1 · response
    Published 6 October 2017

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Meet with all receptionists and nurses to address the protocols.

    Verbatim wording from the response

    “I enclose copies of our Repeat Prescribing Protocol; this includes the ‘Protection on Prescribing’ including hospital letters.”

    Source location

    2017-0225-Response-by-Grasmere-Surgery
    Page 1 · response
    Published 6 October 2017

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Arrange a follow-up meeting in three months to review how the prescribing protocol is working within the practice.

    Verbatim wording from the response

    “A further meeting will be arranged in three month's time to review how the Prescribing Protocol has been working within the Practice.”

    Source location

    2017-0225-Response-by-Grasmere-Surgery
    Page 1 · response
    Published 6 October 2017

    Open published response
  8. Mid Kent and Medway

    AI-generated summary

    Claire Joan Elizabeth MEDHURST · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Claire Medhurst was admitted after a polypharmacy overdose, was discharged after treatment, and was readmitted with abdominal pain and severe liver abnormalities. Her acute liver failure was not recognised or treated for about six hours before she deteriorated and died on 24 February 2017. Concerns included the lack of cautionary advice about further use of paracetamol or ibuprofen at discharge and the failure of the laboratory to alert clinicians to abnormal results and toxic paracetamol levels.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure of haematology laboratory alerting for abnormal ALT and toxic paracetamol results

    Wider context from the report

    “(2) The treating clinicians did not receive an alert from the haematology laboratory for the abnormal results for ALT and toxic levels of paracetamol ”

    Source location

    Claire Joan Elizabeth MEDHURST · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Implement an automated paracetamol phone-trigger and ALT alert prompting laboratory staff to telephone critical results to requesting clinicians.

    Verbatim wording from the response

    “2. As a result of this incident an algorithm has been written to add a ‘paracetamol to phone’ trigger test. Furthermore, on the first occurrence of an ALT level outside of the safe range (>825), the system flags a reminder to the laboratory staff to telephone it through to the requesting clinician. This flagging system was implemented on 5th September 2017 and applies to all tests were the levels are outside of the safe range and require immediate actions by a clinician. The Biochemistry Department “when to telephone a result” document is attached as appendix 5.”

    Source location

    2017-0270-Response-by-Medway-NSH-Trust
    Page 3 · response
    Published 25 November 2017

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Audit compliance with SBAR reporting and associated critical-result protocols.

    Verbatim wording from the response

    “3. An audit will be conducted in October 2017 to measure compliance with SBAR and the associated protocols, and ensure Trust procedures are being adhered to.”

    Source location

    2017-0270-Response-by-Medway-NSH-Trust
    Page 3 · response
    Published 25 November 2017

    Open published response
  9. Surrey

    AI-generated summary

    Hayley Denise Sheehan · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Hayley Denise Sheehan collapsed and died at home on 22 November 2016 after unintentionally overdosing on prescription Tramadol; the medical cause of death was Tramadol toxicity. The court found that early requests for repeat prescriptions had not been identified or acted upon, allowing her to obtain a significant amount of excess medication. The principal concern was that the prescription process relied heavily on administrators identifying early requests, while the surgery’s software did not automatically flag them.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to reliably identify and flag early repeat prescription requests for GP review

    Wider context from the report

    “The procedure for issuing repeat prescriptions relies heavily upon the prescription administrators identifying and flagging early requests to GPs. As far as ████████ was aware, the software used by the surgery does not automatically identify early prescription requests. Consideration should be given to introducing more safeguards to ensure that early requests for repeat prescriptions are identified and drawn to the attention of a GP. This should include giving consideration to whether the relevant software can be adapted to automatically identify early prescription requests. ”

    Source location

    Hayley Denise Sheehan · Prevention of Future Deaths report
    Page 3 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Configure an EMIS Web pop-up alert for early controlled-drug prescription requests, enabling staff to flag requests for GP attention.

    Verbatim wording from the response

    “A meeting was held at the Moat House Surgery attended by the GP Partners, Practice Manager, IT Manager and the lead clinical administrator on 17th August 2017. Following discussion at the meeting an e-mail was sent to EMIS Health, the provider of our clinical software system EMIS Web, requesting changes to the EMIS prescribing process, so that early prescription requests are ‘flagged up’. I enclose copies of the correspondence. In the meantime, our IT Manager has developed a pop-up box within patients’ notes which alerts the issuer of a prescription to the fact that a previous prescription had been issued less than 30 days previously. The pop-up box can be configured to flag an early request for all drugs, a particular drug, or drug ingredient. It is currently configured to a predefined list of products with controlled drug ingredients.”

    Source location

    2017-0324-Response-by-The-Moat-House-Surgery
    Page 1 · response
    Published 3 December 2017

    Open published response
  10. West Yorkshire (West)

    AI-generated summary

    Pauline Taylor · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Pauline Taylor, who was bedbound and living alone, died in her home after a fire developed around her bed on 30 May 2015. The report identified concerns about the fire risks of low-paraffin emollient creams, limited warnings and awareness of those risks, the contribution of the airflow mattress, and the absence of a further risk assessment after her circumstances changed.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to provide private community-care companies with alerts about relevant medicines and medical devices

    Wider context from the report

    “(5) Private companies who provide carers in the community do not receive alerts with regard to medicines and medical devices which could impact on the risk assessments and the manner in which carers working in the private sector provide care. ”

    Source location

    Pauline Taylor · Prevention of Future Deaths report
    Page 4 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Continue reviewing methods for communicating important healthcare information to healthcare professionals and the public.

    Verbatim wording from the response

    “MHRA is continually reviewing methods of communicating important healthcare information to healthcare professionals and members of the public. However, communication to the general public is a challenging area for all aspects of healthcare. The MHRA does publish Medical Device Alerts and Drug Alerts issued via the Central Alerting System (CAS). Within CAS there are thousands of subscribers from organisations in the independent/private sectors, with frequent requests received at the helpdesk to add new subscribers and alter existing records. This is a well-established and effective mechanism for communicating important safety information to healthcare professionals throughout the NHS and private health sectors.”

    Source location

    2017-0330-Response-by-MHRA
    Page 3 · response
    Published 21 July 2017

    Open published response
Back to top

Data last updated 7 September 2026